Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» OCA
OCA
Intercept’s Fibrosis Success Gives Galectin High Hope
Wall St Cheat Sheet
Tue, 01/28/14 - 12:17 pm
Intercept Pharma
Galectin
Conatus Pharmaceuticals
OCA
Liver Drug Race: Intercept Pharma Vs. Rivals
Seeking Alpha
Mon, 01/27/14 - 08:21 am
Intercept Pharma
liver disease
OCA
Conatus Pharmaceuticals
Gilead Sciences
Galectin
NASH
non-alcoholic fatty liver disease
Intercept Pharmaceuticals' Above $300 -- More Mega Millions On The Way?
Forbes
Fri, 01/17/14 - 05:28 pm
OCA
Intercept Pharma
Intercept CEO says new drug could treat ‘next tsunami’ in liver disease
Marketwatch
Wed, 01/15/14 - 05:21 pm
Intercept Pharma
liver disease
nonalcoholic steatohepatitis
OCA
The Short Story Of Intercept Pharmaceuticals (Part I): A Conference Call With Expert Physicians
Seeking Alpha
Tue, 01/14/14 - 10:44 am
Intercept Pharma
physicians
OCA
Amarin Out, Intercept Pharma In at JPMorgan Healthcare Confab
TheStreet.com
Mon, 01/13/14 - 08:40 am
Amarin
Intercept Pharma
JPMHC 2014
OCA
Vascepa
Intercept OCA likely to qualify for accelerated approval, says Oppenheimer
Yahoo/Fly on the Wall
Thu, 07/11/13 - 10:34 am
Intercept Pharma
OCA
primary biliary cirrhosis
Pages
« first
‹ previous
1
2